Last reviewed · How we verify
NCT05786300
Effect of NMES+ on Hamstring Lesion (3a/3b)
NA trial testing NMES+ in Hamstring Injury in 20 participants. Status unknown.
1 September 2024
Quick facts
| Lead sponsor | Università degli studi di Roma Foro Italico |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 20 |
| Start date | 1 November 2023 |
| Primary completion | 1 September 2024 |
| Estimated completion | 1 December 2024 |
Drugs / interventions tested
- NMES+
- Rehab
Conditions studied
- Hamstring Injury — all drugs for Hamstring Injury →
- Muscle Rupture — all drugs for Muscle Rupture →
- Hamstring Sprain — all drugs for Hamstring Sprain →
Sponsor
Università degli studi di Roma Foro Italico
Who can join
Adults 18 to 40, any sex, with Hamstring Injury or Muscle Rupture. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to analyze the effect of the electrical stimulation superimposed onto movement in healthy semi-professional athletes who sustained a type 3a/3b hamstring strain injury. The main questions it aims to answer are: * Is NMES+ useful for the treatment of type 3a/3b hamstring strain injury? * Does NMES+ improve the quality of the injured muscle tissue? Participants will follow a 3 week protocol, following the latest evidence available.\[describe the main tasks participants will be asked to do, treatments they'll be given and use bullets if it is more than 2 items\]. If there is a comparison group: Researchers will compare \[insert groups\] to see if \[insert effects\].
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05786300
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of NMES+
Trials testing the same drug.
- NCT07162636 — ELECTRICAL STIMULATION AND EXERCISE FOR MUSCLE LOSS IN CIRRHOSIS PATIENTS · NA · not yet recruiting
Other recruiting trials for Hamstring Injury
Currently open trials in the same condition.
- NCT07421570 — The Effect of Capacitive and Resistive Electrical Transfer Therapy on Hamstring Injuries · NA · recruiting
- NCT07484698 — Myofascial Release Combined With FIFA 11+: Effects on Hamstring Flexibility and Injury Risk · NA · recruiting
- NCT07492732 — Comparison of the Effects of Selected Training Methods and SIS Stimulation on Balance, Motor Tests, and Strength · recruiting
- NCT06526728 — Hyperbaric Oxygen Therapy in HAMstring Injury (HOTHAM) Trial · Phase 3 · recruiting
- NCT05345015 — High Frequency RF Current Effects on Muscle Pain and Function · NA · recruiting
Other Università degli studi di Roma Foro Italico trials
Trials by the same sponsor.
- NCT06063915 — Isoinertial Rehabilitation in Recovering Hamstring Strength Following Surgical Anterior Cruciate Ligament Reconstruction · NA · unknown
- NCT04878679 — Effect of WB-EMS on Parkinson's Disease · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05786300 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Università degli studi di Roma Foro Italico
- Last refreshed: 26 September 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05786300.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing